CHEST 2024 Morning Preview: Monday

CHEST 2024 Morning Preview: Monday

Suivant

When “More Treatment” Isn’t Better: A Stage II Lung Cancer Case

A real patient story demonstrates how CHEST guideline recommendations can be applied in stage II lung cancer when care decisions evolve as new information becomes available. The episode emphasizes multidisciplinary collaboration, evidence-based care, and tailoring decisions to th ...  Afficher plus

From Resection to Risk Reduction: A Stage II Story About Mutations, Meds, and Moving On

A real patient story illustrates how CHEST guideline recommendations can support care planning in stage II lung cancer. The discussion highlights how guideline-based care can help clinicians explain options clearly, align next steps, and support shared decision-making over time. ...  Afficher plus

Épisodes Recommandés

March 2025 CHEST Journal Editor Highlights
CHEST Journal Podcasts

CHEST March 2025, Volume 167, Issue 3 CHEST journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST March 2025 issue, including an exploration of the effectiveness of guideline-recommended activities for children with asthma ...  Afficher plus

October 2024 CHEST Editor Highlights
CHEST Journal Podcasts

CHEST October 2024, Volume 166, Issue 4 CHEST® journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST October 2024 issue, including research into characteristics of adults with severe asthma in childhood, the association of ...  Afficher plus

Ophthalmology Reviews: A New Frontier in the Ophthalmology Family of Journals
Ophthalmology Journal

Ophthalmology Editor-in-Chief, Russell Van Gelder, MD, PhD, and our new Associate Editor, Laura Downie, BOptom, PhD, guest host this special episode introducing "Ophthalmology Reviews." <span style= "mso-spacerun: yes;"> </span>Ophthalmology Reviews ...

  Afficher plus

2024 State of Lung Cancer: The Hopes and Hurdles of Precision Oncology with Dr. Jacob Sands
Lungcast

For a probing discussion detailing the American Lung Association’s recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targete ...  Afficher plus